SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001387131-23-000472
Filing Date
2023-01-23
Accepted
2023-01-20 21:58:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM S-3 smmt-s3a_012023.htm S-3/A 643897
2 CONSENT OF PRICEWATERHOUSECOOPERS LLP, A DELAWARE LIMITED LIABILITY PARTNERSHIP ex23-1.htm EX-23.1 3397
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP, A UNITED KINGDOM ENTITY ex23-2.htm EX-23.2 3265
4 GRAPHIC smmt-007.jpg GRAPHIC 46104
  Complete submission text file 0001387131-23-000472.txt   715337
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-268932 | Film No.: 23542416
SIC: 2834 Pharmaceutical Preparations